Havrix 720 Junior 720 Unit

HAVRIX 720 Junior is a hepatitis A vaccine designed for children, providing protection against the hepatitis A virus. This inactivated suspension is administered intramuscularly and is manufactured by GlaxoSmithKline Inc.

HAVRIX 720 Junior is used to prevent hepatitis A infection in children. Hepatitis A is a viral liver disease that can cause mild to severe illness. This vaccine is typically administered to children to build immunity against the virus, helping to reduce the risk of infection and its associated symptoms.

Common effects of HAVRIX 720 Junior may include mild soreness, redness, or swelling at the injection site. Some children may also experience mild fever, headache, or fatigue following vaccination. These effects are usually temporary and resolve on their own.

HAVRIX 720 Junior should be stored as per the manufacturer's instructions to maintain its efficacy. It is important to inform healthcare providers about any allergies or medical conditions before administration. Always follow the advice of a healthcare professional regarding vaccination schedules and precautions.

There are no specific interactions widely reported with HAVRIX 720 Junior. However, it is always advisable to inform healthcare providers about any medications or supplements being taken to ensure safety. Avoid taking alcohol or other medications that may weaken the immune system without consulting a healthcare professional.